These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 28325641)

  • 1. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence study of genetically defined skeletal muscle channelopathies in England.
    Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG
    Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
    Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
    Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle channelopathies.
    Vivekanandam V; Jayaseelan D; Hanna MG
    Handb Clin Neurol; 2023; 195():521-532. PubMed ID: 37562884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing.
    Vivekanandam V; Jaibaji R; Sud R; Ellmers R; Skorupinska I; Germaine L; James N; Holmes S; Mannikko R; Jayaseelan D; Hanna MG
    Neuromuscul Disord; 2023 Mar; 33(3):270-273. PubMed ID: 36796140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium Channelopathies of Skeletal Muscle.
    Cannon SC
    Handb Exp Pharmacol; 2018; 246():309-330. PubMed ID: 28939973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation spectrum and health status in skeletal muscle channelopathies in Japan.
    Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP
    Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal Muscle Channelopathies.
    Vivekanandam V; Munot P; Hanna MG; Matthews E
    Neurol Clin; 2020 Aug; 38(3):481-491. PubMed ID: 32703462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.
    Ryan AM; Matthews E; Hanna MG
    Curr Opin Neurol; 2007 Oct; 20(5):558-63. PubMed ID: 17885445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies.
    Bissay V; Van Malderen SC; Keymolen K; Lissens W; Peeters U; Daneels D; Jansen AC; Pappaert G; Brugada P; De Keyser J; Van Dooren S
    Eur J Hum Genet; 2016 Mar; 24(3):400-7. PubMed ID: 26036855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A zebrafish model of nondystrophic myotonia with sodium channelopathy.
    Nam TS; Zhang J; Chandrasekaran G; Jeong IY; Li W; Lee SH; Kang KW; Maeng JS; Kang H; Shin HY; Park HC; Kim S; Choi SY; Kim MK
    Neurosci Lett; 2020 Jan; 714():134579. PubMed ID: 31669315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nondystrophic myotonias.
    Heatwole CR; Moxley RT
    Neurotherapeutics; 2007 Apr; 4(2):238-51. PubMed ID: 17395134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle channelopathies and electrophysiological approach.
    Cherian A; Baheti NN; Kuruvilla A
    Ann Indian Acad Neurol; 2008 Jan; 11(1):20-7. PubMed ID: 19966974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic variability in childhood of skeletal muscle sodium channelopathies.
    Yoshinaga H; Sakoda S; Shibata T; Akiyama T; Oka M; Yuan JH; Takashima H; Takahashi MP; Kitamura T; Murakami N; Kobayashi K
    Pediatr Neurol; 2015 May; 52(5):504-8. PubMed ID: 25724373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Status myotonicus" in Na
    Rempe T; Subramony SH
    Neuromuscul Disord; 2020 May; 30(5):424-426. PubMed ID: 32327288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotonia.
    Webb J; Cannon SC
    Neurology; 2008 Mar; 70(10):755-61. PubMed ID: 17898326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.
    Jurkat-Rott K; Lehmann-Horn F
    Neurotherapeutics; 2007 Apr; 4(2):216-24. PubMed ID: 17395131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.
    Statland JM; Barohn RJ
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1598-614. PubMed ID: 24305449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited ion channel disorders.
    Surtees R
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S199-203. PubMed ID: 11216900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle channelopathies.
    Saperstein DS
    Semin Neurol; 2008 Apr; 28(2):260-9. PubMed ID: 18351527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.